These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3840807)

  • 1. Determination of atracurium, laudanosine and related compounds in plasma by high-performance liquid chromatography.
    Simmonds RJ
    J Chromatogr; 1985 Oct; 343(2):431-6. PubMed ID: 3840807
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of atracurium in plasma by high-performance liquid chromatography.
    Stiller RL; Brandom BW; Cook DR
    Anesth Analg; 1985 Jan; 64(1):58-62. PubMed ID: 3838124
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro degradation of atracurium in human plasma.
    Stiller RL; Cook DR; Chakravorti S
    Br J Anaesth; 1985 Nov; 57(11):1085-8. PubMed ID: 3840382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of atracurium and laudanosine in human plasma by high-performance liquid chromatography.
    Varin F; Ducharme J; Besner JG; Théorêt Y
    J Chromatogr; 1990 Aug; 529(2):319-27. PubMed ID: 2229251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of atracurium and laudanosine in dog plasma during cardiopulmonary bypass by high performance liquid chromatography with fluorometric detection].
    Yang Y; Chen M; Kuang Y; Ye L; Zhang W
    Se Pu; 2013 Jun; 31(6):572-6. PubMed ID: 24063198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-performance liquid chromatographic method for the determination of atracurium and laudanosine in human plasma. Application to pharmacokinetics.
    Farenc C; Audran M; Lefrant JY; Mazerm I; Bressolle F
    J Chromatogr B Biomed Sci Appl; 1999 Mar; 724(1):117-26. PubMed ID: 10202964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro degradation of atracurium in human plasma.
    Merrett RA; Thompson CW; Webb FW
    Br J Anaesth; 1983 Jan; 55(1):61-6. PubMed ID: 6687375
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification and quantitation of six non-depolarizing neuromuscular blocking agents by LC-MS in biological fluids.
    Sayer H; Quintela O; Marquet P; Dupuy JL; Gaulier JM; Lachâtre G
    J Anal Toxicol; 2004 Mar; 28(2):105-10. PubMed ID: 15068563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simplified method for the determination of atracurium and laudanosine in pig plasma by high-performance liquid chromatography and fluorimetric detection.
    Schopfer C; Benakis A
    J Chromatogr; 1990 Mar; 526(1):223-7. PubMed ID: 2341536
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetics of atracurium in acute hepatic failure (with acute renal failure).
    Ward S; Neill EA
    Br J Anaesth; 1983 Dec; 55(12):1169-72. PubMed ID: 6689126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A model for atracurium?
    Hull CJ
    Br J Anaesth; 1983 Feb; 55(2):95-6. PubMed ID: 6687551
    [No Abstract]   [Full Text] [Related]  

  • 12. Simple high-performance liquid chromatographic method for the analysis of the non-depolarizing neuromuscular blocking drugs in clinical anaesthesia.
    Bjorksten AR; Beemer GH; Crankshaw DP
    J Chromatogr; 1990 Nov; 533():241-7. PubMed ID: 1982003
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of atracurium besylate in healthy patients (after a single i.v. bolus dose).
    Ward S; Neill EA; Weatherley BC; Corall IM
    Br J Anaesth; 1983 Feb; 55(2):113-8. PubMed ID: 6687550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined pharmacokinetic and pharmacodynamic study of a single bolus dose of atracurium.
    Ward S; Wright D
    Br J Anaesth; 1983; 55 Suppl 1():35S-38S. PubMed ID: 6688015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of atracurium besylate in human plasma.
    Neill EA; Jones CR
    J Chromatogr; 1983 May; 274():409-12. PubMed ID: 6688255
    [No Abstract]   [Full Text] [Related]  

  • 16. The pharmacokinetics and pharmacodynamics of atracurium in patients with and without renal failure.
    Fahey MR; Rupp SM; Fisher DM; Miller RD; Sharma M; Canfell C; Castagnoli K; Hennis PJ
    Anesthesiology; 1984 Dec; 61(6):699-702. PubMed ID: 6239574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of renal failure on laudanosine excretion in man.
    Fahey MR; Rupp SM; Canfell C; Fisher DM; Miller RD; Sharma M; Castagnoli K; Hennis PJ
    Br J Anaesth; 1985 Nov; 57(11):1049-51. PubMed ID: 3840380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentrations of atracurium and laudanosine in cerebrospinal fluid and plasma during intracranial surgery.
    Eddleston JM; Harper NJ; Pollard BJ; Edwards D; Gwinnutt CL
    Br J Anaesth; 1989 Nov; 63(5):525-30. PubMed ID: 2605068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein binding of atracurium and other short-acting neuromuscular blocking agents and their interaction with human cholinesterases.
    Foldes FF; Deery A
    Br J Anaesth; 1983; 55 Suppl 1():31S-34S. PubMed ID: 6134540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged infusion of atracurium in an infant.
    Tabardel Y; Paquay T; Senterre J
    Dev Pharmacol Ther; 1990; 15(1):52-6. PubMed ID: 2242710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.